Last night, Dr. Jan Holmgren received the 24th annual Albert B. Sabin Gold Medal Award in honor of his pioneering work in mucosal immunology and leadership in the development the world’s first oral cholera vaccine. Guests gathered at the National Academy of Sciences building in Washington, D.C., under a mural of Prometheus inscribed “hearken to the miseries that beset mankind” – a fitting setting for the celebration of a career spent fighting an ancient disease of the poor.
Every year, the Albert B. Sabin Gold Medal Award is given to a distinguished member of the public health community who has made extraordinary contributions in the field of vaccinology. This year's award will honor Jan Holmgren, M.D., Ph.D., for his pioneering contributions to oral vaccine research and mucosal immunology, as well as his leadership in the discovery of the world's first effective oral cholera vaccine.
Overseas travelers can sometimes bring back unwanted souvenirs — with tragic consequences. A localized outbreak of typhoid in Auckland, New Zealand has taken the life of one patient and affected 20 others. Public health authorities believe that a traveler to a typhoid-endemic country may have unknowingly contracted the disease and carried it back into the country.

For more than two decades, the Sabin Vaccine Institute has been dedicated to reducing needless human suffering from vaccine-preventable and neglected tropical diseases (NTDs). As we enter the next decade, Sabin will draw from the legacy of Dr. Albert B.